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study question: What are the dropout rates in lifestyle intervention programs (LIPs) for overweight and obese infertile women and
can intervention- or patient-related baseline factors associated with dropout be identiﬁed in these women?
summary answer: The median dropout rate was 24% in overweight and obese infertile women who participated in a LIP; clinical
useful intervention or patient-related factors associated with dropout could not be identiﬁed.
what is known already: Overweight and obese infertile women might improve their chance of conception when they improve
their lifestyle and lose weight. Dropout from LIPs reduces the chance of losing considerable weight and is therefore considered to be an
important limiting factor of the success of LIPs.
study design, size, duration: This systematic review included 15 studies published between January 1980 and December 2012.
participants/materials, setting, methods: The included studies investigated the effect of LIPs for overweight and obese
infertile womenwith infertility. From these studies, dropout rates and intervention- and patient-related baseline factors associatedwith dropout,
as well as weight loss and pregnancy rates, were recorded.
main results and the role of chance: There were 15 studies identiﬁed, of which 10 reported dropout rates. The median
dropout rate was 24% (range: 0–31%). Four studies reported baseline characteristics of women who dropped out, but modiﬁable predictors
of dropout could not be identiﬁed.Weight loss and pregnancy rates were lower in womenwho dropped out than in womenwho completed the
LIPs.
limitations, reasons for caution: There were limited numbers of studies investigating patient-related factors associated with
dropout. The heterogeneity in the studies precluded us from drawing ﬁrm conclusions on the relation between the type of intervention and
dropout.
wider implications of the findings: Dropout from LIPs is a major drawback because it predisposes to less weight loss and
lower pregnancy rates. Identiﬁcation of predictors of dropout is needed to identify overweight and obese infertile women who are prone for
dropout. These women might beneﬁt from extra support and monitoring, to potentially increasing adherence rates, weight loss and pregnancy
chances.
study funding/competing interest(s):M.A.Q.M.was supported by a research grant from theDutchOrganization forHealth
Research andDevelopment (ZonMw). The department of obstetrics and gynaecology received research grants fromMerck Sharpe and Dohme
BV, feering pharmaceuticals, Merck Serono, the Netherlands.
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Overweight [body mass index (BMI) 25–29.9 kg/m2] and obese
(BMI ≥ 30 kg/m2) women have reduced chances of spontaneous con-
ception and lower success rates with fertility treatment (Gesink Law
et al., 2007; Maheshwari et al., 2007; Ramlau-Hansen et al., 2007;
van der Steeg et al., 2008; Bellver et al., 2010). It has been shown
that losing weight can improve the chance of conception in this speciﬁc
patient category (Clark et al., 1998; Huber Buchholz et al., 1999; Miller
et al., 2008). Overweight and obese infertile women are therefore
advised to participate in lifestyle intervention programs (LIPs) to
lose weight before entering fertility programs (National Institute for
Clinical Excellence, 2004).
In LIPs designed for overweight and obese men and women to di-
minish long-term health risks, dropout rates have been reported to be
up to 77% (Davis and Addis, 1999; Honas et al., 2003; Inelmen et al.,
2005; Finley et al., 2007). This is considered as an important limiting
factor in the success of LIPs because dropout is related to little
weight change (Finley et al., 2007). Hence, identifying patients at risk
of dropping out might contribute to the development of strategies to
increase adherence rates. In LIPs addressing metabolic health risks of
obesity in men and women, research has focused on patient-related
factors associated with increased dropout risk. Socio-demographic
factors including full-time employment, psychological factors such as de-
pression and lower quality of life and behavioral factors like smoking
have all been shown to be associated with increased dropout rates
and might therefore be considered as predictors for dropout (Clark
et al., 1996; Teixeira et al., 2004; Inelmen et al., 2005).
Not only patient-related factors, but also the type of intervention
may inﬂuence the dropout risk. In a meta-analysis on the long-term
effect of structured weight-loss programs, it was demonstrated that
very low calorie diets, in which an intake of less than 800 kcal per
day was advised, led to higher dropout rates than diets in which sub-
jects were advised to lower their calorie intake by 600 kcal per day
(Anderson et al., 2001).
Due to the emotional and social burden of infertility (Greil, 1997),
combined with the short-term goal of conception, it is conceivable that
overweight and obese infertile women are more motivated to achieve
weight loss than women and men who have to lose weight for long-term
health improvement. However, dropout rates in LIPs for overweight and
obese infertile women have not been systematically reported and little is
known about intervention- and patient-related baseline factors asso-
ciated with dropout in this speciﬁc patient population.
We therefore systematically reviewed the literature on LIPs in over-
weight and obese infertile women to investigate dropout rates and to
identify possible intervention- and patient-related factors associated
with dropout. In addition, we aimed to compare weight loss and preg-
nancy rates between overweight and obese infertile women who
dropped out of the LIPs and women who completed these programs,
to estimate the effect of dropout on these important clinical outcome
measures.
Materials and Methods
We searched PubMed, Embase and the Cochrane Library for studies, pub-
lished in the English literature between January 1980 and December 2012,
investigating the effect of LIPs in overweight and obese infertile women.
Women with chronic anovulation or ovulatory women who had tried to
conceive for at least 1 year were deﬁned as infertile. Search terms used
included BMI, overweight, obesity, infertility, polycystic ovary syndrome
(PCOS), lifestyle, intervention program, diet, exercise and weight loss
(see Supplementary data, Appendix SI for the full list of key words).
Two reviewers independently screened titles and abstracts of all
retrieved studies (M.A.Q.M. and W.K.H.K.). Full text reports of all
studies that were likely to investigate the effect of LIPs in overweight
and obese infertile women were obtained. Reviews were excluded. The
references of the selected articles were checked for relevant and related
publications. We attempted to contact the authors for additional informa-
tion, if deemed necessary. Studies in which it was unclear whether the
patient population tried to conceive and studies in which birth control
was advised during the intervention program were excluded.
We extracted information on study design, number of participants,
baseline BMI, design of the LIP, mean weight loss in completers and drop-
outs, spontaneous pregnancy rates during the LIP and during follow-up of
the LIP, dropout rates and reasons for dropout. Dropout was deﬁned as
withdrawal from the program before completing the LIP. Women who dis-
continued the LIP because of pregnancy were not considered as women
who dropped out.
To evaluate a possible association between the type of intervention and
dropout and pregnancy rates, we extensively mapped the LIP designs of
the included studies. Different study arms were compared to detect pos-
sible associations between a speciﬁc type of intervention and dropout and
pregnancy rates. In addition, possible associations between baseline
patient characteristics and dropout reported in all included studies were
investigated.
Disagreement was resolved by discussion and consensus. If consensus
could not be reached, a third reviewer (A.H.) was consulted.
Statistics
The weighted average, which corrects for sample size, was used to
compare pregnancy and dropout rates between the different types of
intervention of the included studies.
Results
Our initial literature search generated 609 studies (Fig. 1). After screen-
ing the titles and abstracts, 96 articles were identiﬁed as potentially eli-
gible. After reading these full-text publications, 81 articles were
Figure 1 Flow chart.











excluded (see separate reference list in Supplementary data, Appendix
S2), whereas data of the remaining 15 studies were included and subse-
quently analyzed. Table 1 summarizes the detailed content of the
included studies. Data reported in Table 1 were extracted from the ori-
ginal articles. Of the 15 included studies, 13 were prospective cohort
studies and two were RCTs. The participants were overweight and
obese infertile women with a BMI ranging from 27 up to 43 kg/m2.
The median duration of the programs was 24 weeks (range 6–32
weeks). Of the 15 included studies, 14 reported pregnancy rates: the
median pregnancy rate was 23% (range 1–56%). The amount of
weight loss in the included studies could not be summarized, as this
was not reported in a consistent way. Ten studies reported dropout
rates: the median dropout rate was 24% (range 0–31%). Three
studies provided reasons for dropout.
Type of intervention and dropout
We extensively mapped the LIP designs of the included studies; differ-
ent study arms within the studies were thereby allocated to the differ-
ent intervention strategies.
(i) Dietary regimen alone (n ¼ 6): In total, 118 women participated,
of whom 32 women conceived (weighted average 6%, 1 program
did not report pregnancy rates), whereas 20 dropped out
(weighted average 4%, 3 programs did not report dropout
rates). The median duration of these programs was 24 weeks
(range 6–24 weeks) (Bates and Whitworth, 1982; Harlass et al.,
1984; Bu¨tzow et al., 2000; Crosignani et al., 2003; Qublan et al.,
2007; Palomba et al., 2008).
(ii) Dietary regimen combined with exercise program (n ¼ 8): In
total, 310 women participated, of whom 56 women conceived
(weighted average 11%), whereas 96 women dropped out
(weighted average 7%; 2 programs did not report dropout
rates). The median duration of the programs was 24 weeks
(range 6–32 weeks) (Andersen et al., 1995; Hollmann et al.,
1996; Clark et al., 1998; Huber Buchholz et al., 1999; Miller
et al., 2008; Karimzadeh and Javedani, 2010; Palomba et al.,
2010; Kuchenbecker et al., 2011).
(iii) Structured exercise program (n ¼ 1): In total, 20 women partici-
pated in this program and 7 conceived (35%), whereas 3 women
dropped out (15%). The duration of the program was 24 weeks
(Palomba et al., 2008).
(iv) Dietary regimen, exercise program and medication or a placebo
(n¼ 3): In total, 175 women participated, of whom 9 conceived
(weighted average 3%), whereas 17 women dropped out (weighted
average 7%). The median duration was 24 weeks (range 6–24
weeks) (Tang et al., 2006; Palomba et al., 2010).
(v) Medication only (n¼ 5): In total, 322 women participated of whom
43 women conceived (weighted average 11%). Only one study
reported dropout rates (no dropout). The median duration was
18 weeks (range 3–24 weeks) (Qublan et al., 2007; Karimzadeh
and Javedani, 2010; Palomba et al., 2010).
Baseline characteristics of participants
associated with dropout
In four studies, baseline characteristics of dropouts were described.
Kuchenbecker et al. (2011) found higher free testosterone and total
testosterone levels in women who dropped out (Kuchenbecker
et al., 2011). Clark et al. (1998) did not observe different baseline
characteristics in dropouts and completers, but showed that dropouts
underwent signiﬁcantly less cycles of fertility treatment prior to the
LIP, when compared with women who completed the LIP (Clark
et al., 1998). Tang et al. (2006) could not demonstrate any differences
in baseline characteristics between completers and dropouts (Tang
et al., 2006). Crosignani et al. (2003) deﬁned dropout as not losing
weight within 6 months. They investigated baseline patient character-
istics that might predict weight loss and found that the fat mass ratio
was the only anthropometric variable that was signiﬁcantly associated
with the probability of losing weight: the lower the basal ratio, the
higher the probability of losing weight (Crosignani et al., 2003).
Weight loss and pregnancy rates in dropouts
Three studies reported the amount of weight loss and/or pregnancy
rates in women who dropped out (Clark et al., 1998; Crosignani
et al., 2003; Kuchenbecker et al., 2011). These studies showed that
completers lost more weight than dropouts. In addition, none of
the dropouts conceived spontaneously during or within the month
after dropout (Table 1).
Discussion
We performed a systematic review on dropout rates and intervention
and patient-related baseline factors associated with dropout in LIPs for
overweight and obese infertile women. We identiﬁed 15 studies, of
which 10 studies provided data on dropout. In these studies, a
median dropout rate of 24% was observed. Lower dropout rates
have been reported in studies with a relatively short-time frame (6
weeks) and substantial higher dropout rates are reported in studies
with longer lasting LIPs (see Table 1). As adherence to a LIP is asso-
ciated with increased weight loss and it is essential for a LIP to be suc-
cessful (Dansinger et al., 2005), dropout rates up to 24% should be
considered representative. Four studies reported baseline characteris-
tics of women who dropped out. Although no clinically useful and
modiﬁable predictors for dropout could be identiﬁed in these
studies, it was shown that dropouts lost less weight than completers
and that they did not conceive spontaneously during or within 1
month after dropout.
From these data, it can be concluded that dropout in LIPs for over-
weight and obese infertile women is a clinically important problem.
Therefore, it is important to identify modiﬁable predictors for
dropout, as this might contribute to the development of tailored strat-
egies, thereby improving adherence of participants to LIPs (Fabricatore
et al., 2009).
To the best of our knowledge, this systematic review is the ﬁrst
review in which dropout rates and factors leading to dropout from
LIPs are investigated in overweight and obese infertile woman. A
drawback of the current review is the difﬁculty of comparing the
LIPs due to the heterogeneity of the available studies. Another draw-
back is the limited numbers of studies that investigated the association
between patient-related baseline factors and dropout, whereas
none of the included studies investigated the association between
intervention-related factors and dropout.
To overcome these drawbacks, we aimed to detect associations
between intervention-related factors and dropout by comparing the












Table I Characteristics of the included studies.
Study Study design Participants Baseline BMI of
all participants
(kg/m2)












28.8 (mean) Dietary regimen designed to decrease body weight
at the rate of 500 g per week
Guidance of a therapeutic dietician
Weight loss: 9.6 kg
Pregnancy rates: 56% (n ¼ 10)
28% (n ¼ 5)
Reasons: not reported







10 infertile women 37.1+3.3
(mean, SEM)
6-weeks very low calorie diet consisting of
650 kcal/day followed by a 4-week recovery period
(normocaloric diet)
Weight loss: 11% weight
reduction
(mean BMI 24.1 kg/m2)
Pregnancy rates: not reported










24-weeks dietary regimen consisting of a diet
containing 1200 kcal per day
Aerobic exercise was recommended
Regular controls and weight assessment were
carried out every 6–8 weeks
Weight loss: 25 women lost
5% of initial weight
Pregnancy rates: 30% (n ¼ 10)
within 12 months
24% (n ¼ 8)
Reasons: did not reach 5%
weight loss within 6 months











16–24 weeks dietary regimen consisting of a
calorie-restricted diet of 500 kcal/day. All patients
were followed weekly by the authors
Weight loss: 7–12% weight
loss (range)
Pregnancy rates: 33% (n ¼ 2)
within 6 months after study
termination














1. 24-week structured exercise program (SET): 3
training sessions per week consisting of 30 min
exercising on a bicycle ergometer
2. 24-week hypocaloric hyperproteic diet aimed at
800 kcal deﬁcit per day in combination with weekly




(n ¼ 13): 5.6+1.6 kg,
anovulatory patients (n ¼ 7):
2.0+0.2 kg
2. Ovulatory patients (n ¼ 5):
10.5+4.1 kg, anovulatory




1. 20% (n ¼ 7)
2. 10% (n ¼ 2)
1. 15% (n ¼ 3)
2. 35% (n ¼ 7)
Reasons: not reported














24 weeks during program consisting of:
1. A diet containing 1200–1400 kcal per day
2. 850 mg metformin twice a day





1. 33% (n ¼ 8)
2. 27% (n ¼ 6)


















24-weeks dietary regimen consisting of 4 weeks
421 kcal/day and 20 weeks 1000–1500 kcal/day
Regularly advice to take a daily walk
Monthly examining by a dietician
Weight loss:
2.6 kg after 4 weeks (n ¼ 9)
4.8 kg after 24 weeks (n ¼ 6)
(median)
Pregnancy rates: 22% (n ¼ 2)
11% (n ¼ 1)
Reasons: not reported
Weight loss: not reported
Pregnancy rates: not
reported
(Clark et al., 1998) Prospective cohort
study





24-weeks group treatment program emphasizing
dietary changes and regular exercise containing:
1 h/week exercise with ﬁtness instructor
1 h/week group session with psychiatrist,
dietician or reproductive medicine specialist
Weight loss: 6.3+4.2 kg
Pregnancy rates: 27% (n ¼ 18)
23% (n ¼ 20)
Reasons: work and other
commitments







35 infertile women Between 30.8 and
37.3
32-week dietary regimen consisting of regularly
advice to reduce weekly intake with 5.000–
10.000 kcal
Patients were encouraged to increase physical
activity
Weight loss: 11.6 kg (median)
Pregnancy rates: 29% (n ¼ 10)













24-weeks group treatment program emphasizing
dietary changes and regular exercise containing:
1 h/week exercise with ﬁtness instructor
1 h/week group session with psychiatrist,
dietician or reproductive medicine specialist
Weight loss: 2–5% of starting
weight
Pregnancy rates:
1. 11% (n ¼ 3)
2. 0
1. 17% (n ¼ 3)
2. 40% (n ¼ 4)
Reasons: not reported



















1. 100 mg CC on days 3–7 for a maximum of 3–6
cycles
2. 500 mg Metforminw in a step-up dose till
1500 mg/day for 12–24 weeks
3. Combination of CC and Metforminw as
described above
4. Lifestyle modiﬁcation: dietary regimen consisting
of a deﬁcit of 500 calories per day when compared
with daily requirements in combination with 3–5
times per week 20–60 min exercising
Weight loss: not reported
Pregnancy rates:
1. 22% (n ¼ 11)
2. 14% (n ¼ 13)
3. 14% (n ¼ 13)
4. 20% (n ¼ 15)














24-week lifestyle program consisting of:
individualized dietary advice (reduction in calorie
intake of ≥ 500 kcal/day)
Individualized exercise program
Behavior modiﬁcation
Guidance of a nurse practitioner every 2 weeks
Weight loss:
Women who resumed
ovulation lost 6.3% of body
weight
Pregnancy rates: 22% (n ¼ 7)
31% (n ¼ 10)
Reasons: not reported
Weight loss: women who
remained anovulatory
(including dropouts) lost
3.0% of body weight
Pregnancy rates: 0%
(Miller et al. 2008) Prospective cohort
study
12 infertile women ≥30 12-week lifestyle program consisting of a 1200–
1500 kcal/day individualized diet and three times
per week ﬁtness sessions of 1 h. Encouraged to
exercise independently throughout the week
Weekly educational sessions on obesity and
infertility
Weight loss: not reported
BMI change: 22.1 kg/m2
Pregnancy rates: 8% (n ¼ 1)
8% (n ¼ 1)
Reasons: not reported
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Table I Continued
Study Study design Participants Baseline BMI of
all participants
(kg/m2)






















1. 6-weeks during SET: 3 training sessions per week
consisting of 30 min cycling and hypocaloric
hyperproteic diet aimed at 1000 kcal deﬁcit per day
2. After 2 weeks of observation, 150 mg CC was
given daily for 5 days (in absence of ovarian
response)
3. 6-week during SET and hypocaloric hyperproteic
diet aimed at 1000 kcal deﬁcit per day. After 2
weeks, 150 mg CC was added daily for 5 days (in
absence of ovarian response)























24-weeks lifestyle modiﬁcation program consisting
of:
Standardized high-carbohydrate low-fat diet
aimed at 500 kcal reduction/day
Encouraging to increase daily exercise by 15 min
Monthly visits with a research dietician
In combination with:
1. Metforminw 850 mg twice a day
2. Placebo medication twice a day
Weight loss:
1. 2.8 kg (1.8–3.9)
2. 21.5 kg (20.3 to
2.6)(mean, 95% CI)
Pregnancy rates:
1. 9% (n ¼ 6)
2. 3% (n ¼ 2)
1. 16% (n ¼ 11)
2. 8% (n ¼ 6)
Reasons: side effects
Weight loss: not reported
Pregnancy rates: not
reported
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different types of intervention of the included studies. Our comparison
showed comparable dropout rates in LIPs consisting of a dietary
regimen only and in LIPs in which a dietary regimen was combined
with an exercise program (weighted average 4 and 7%, respectively).
However, the large heterogeneity in study design, duration of the
LIPs and heterogeneous description of the results in the studies pre-
cluded us from drawing ﬁrm conclusions on the association between
the type of intervention and risk of dropout.
Modiﬁable predictors for dropout could not be identiﬁed. This is in
concordance with the ﬁndings in a large cohort of 114 obese women
with PCOS in which Ladson et al. (2011) investigated whether the
combination of a LIP and Metforminw was better in improving the
PCOS phenotype than a LIP in combination with placebo (Ladson
et al., 2011). They could not identify any association between
dropout and baseline factors such as BMI, hormone levels, lipid para-
meters, ultrasound parameters and psychosocial baseline factors.
Identifying patients at risk for dropout does not only rely on patient-
related baseline factors. In a 6-month weight loss intervention study in
137 post-menopausal obese women, it was suggested that an unsatis-
factory or slow rate of weight loss, especially in the beginning of a
weight loss program, is also associated with dropout (Messier et al.,
2010). Participants who are not losing weight might be discouraged
and have increased their risk of dropout. Understanding the possible
reasons for the slower rate of weight loss may help to improve the
support of these subjects, especially during the start of the LIP
(Messier et al., 2010). Furthermore, weight loss expectations have
been shown to be independent cognitive predictors of dropout
during weight loss programs: higher expectations at baseline lead to
higher dropout rates (Dalle Grave et al., 2005). Self-efﬁcacy, which
is faith in oneself, might play a crucial role in this process (Cochrane,
2008). Patients with high self-efﬁcacy may attach themselves to goals
that are not realistically achievable that, in turn, might lead to a
‘false hope syndrome’: a phenomenon that is characterized by unreal-
istic expectations of self-change attempts (Polivy, 2001; Jones et al.,
2005). On the other hand, patients with an external locus of
control will have low self-efﬁcacy, and it may be hypothesized that
these patients are prone for dropout as well (Cochrane, 2008).
Studies assessing self-efﬁcacy of participants could help to identify
those subjects who are prone for dropout in LIPs for overweight
and obese infertile women. Whether initial inadequate weight loss
and unrealistic goal setting at baseline can predict dropout should
be investigated in this speciﬁc population.
In conclusion, our review shows a median dropout rate of 24% in
overweight and obese infertile women participating in LIPs. Our
data also indicate that women who dropout lose less weight and
have lower spontaneous pregnancy chances than completers. We
could not identify intervention- or patient-related factors associated
with dropout. Future studies should focus on predictors of dropout
in this patient population. This will enable the identiﬁcation of patients
who are prone for dropping out and who might beneﬁt from extra
support and monitoring to increase adherence rates, weight loss
and pregnancy chances.
Supplementary data
Supplementary data are available at http://humrep.oxfordjournals.org/.
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